摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

屈昔多巴杂质6 | 90044-46-5

中文名称
屈昔多巴杂质6
中文别名
——
英文名称
5,6,11,12-tetrahydro-5,11-epimino-dibenzo[a,e]cyclooctene-2,3,8,9-tetraol
英文别名
5,6,11,12-Tetrahydro-5,11-epimino-dibenzo[a,e]cycloocten-2,3,8,9-tetraol;(+/-)-Tetrahydroxypavinane;17-azatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaene-4,5,12,13-tetrol
屈昔多巴杂质6化学式
CAS
90044-46-5
化学式
C16H15NO4
mdl
——
分子量
285.299
InChiKey
FXFLVMCXSZBKTH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    21
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    93
  • 氢给体数:
    5
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    屈昔多巴杂质6乙酸酐三乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以95%的产率得到2,3,8,9-tetraacetoxy-13-acetyl-5,6,11,12-tetrahydrodibenzo[a,e]cycloocten-5,11-imine
    参考文献:
    名称:
    Synthesis of new TNF-α Inhibitors and their biological properties
    摘要:
    New pavine alkaloid derivatives with various substitutions on their aromatic rings and nitrogen atom were prepared and evaluated for their inhibitory activity against TNF-alpha production in mouse macrophages stimulated with LPS. Some compounds showed potent inhibitory activities in vitro and protected mice against lethality of septic shock induced by LPS and D-galactosamine. Copyright (C) 1996 Elsevier Science Ltd
    DOI:
    10.1016/0960-894x(96)00103-5
  • 作为产物:
    描述:
    3-(3,4-dihydroxyphenyl)serine盐酸 作用下, 以 为溶剂, 以62%的产率得到屈昔多巴杂质6
    参考文献:
    名称:
    Synthesis of new TNF-α Inhibitors and their biological properties
    摘要:
    New pavine alkaloid derivatives with various substitutions on their aromatic rings and nitrogen atom were prepared and evaluated for their inhibitory activity against TNF-alpha production in mouse macrophages stimulated with LPS. Some compounds showed potent inhibitory activities in vitro and protected mice against lethality of septic shock induced by LPS and D-galactosamine. Copyright (C) 1996 Elsevier Science Ltd
    DOI:
    10.1016/0960-894x(96)00103-5
点击查看最新优质反应信息

文献信息

  • Synthesis of new TNF-α Inhibitors and their biological properties
    作者:Norio Fujiwara、Yutaka Ueda、Naohito Ohashi
    DOI:10.1016/0960-894x(96)00103-5
    日期:1996.4
    New pavine alkaloid derivatives with various substitutions on their aromatic rings and nitrogen atom were prepared and evaluated for their inhibitory activity against TNF-alpha production in mouse macrophages stimulated with LPS. Some compounds showed potent inhibitory activities in vitro and protected mice against lethality of septic shock induced by LPS and D-galactosamine. Copyright (C) 1996 Elsevier Science Ltd
查看更多

同类化合物

罗通定 屈昔多巴杂质6 N-甲基厚壳桂碱 O-methylcaryachine 2-methoxy-5,6,11,12-tetrahydro-dibenzo[a,e]cyclooctene-5,11-imin-11-carbamide 13,13-dimethyl-5,6,11,12-tetrahydro-5,11-epimino-dibenzo[a,e]cyclooctenium; iodide 2,3,8,9-tetraacetoxy-13-acetyl-5,6,11,12-tetrahydrodibenzo[a,e]cycloocten-5,11-imine 13-[3-(4-fluorophenyl)propyl]-5,6,11,12-tetrahydrodibenzo[a,e]cycloocten-5,11-imine-2,3,8,9-tetrol hydrochloride 13-ethyl-5,6,11,12-tetrahydrodibenzo[a,e]cycloocten-5,11-imine-2,3,8,9-tetrol hydrochloride (+)-caryachine Crychine (+/-)-N-norbisnorargemonine pavine (1S)-5,12-dimethoxy-17-methyl-17-azatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaene-4,13-diol (1S,12S)-16-methoxy-20-methyl-5,7-dioxa-20-azapentacyclo[10.7.1.02,10.04,8.013,18]icosa-2,4(8),9,13,15,17-hexaen-15-ol escholtzine (-)-bisnorargemonine Argemonine (-)-argemonine (+/-)-N-ethoxycarbonylpavine 1-[(1S,9R)-4,5,12,13-tetramethoxy-17-azatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaen-17-yl]ethanone (1S,9R)-4,5,12,13-tetramethoxy-17-methyl-17-azatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaene (1R,9S)-4,5,12,13-tetramethoxy-17-methyl-17-azoniatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaene (1S,9S)-4,5,12,13-tetramethoxy-17-methyl-17-azoniatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaene (1S,9S)-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.7.1.02,7.010,15]heptadeca-2(7),3,5,10,12,14-hexaene-3,12-diol 1-[(1S,9S)-4,5,12,13-tetramethoxy-17-azatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaen-17-yl]ethanone (1R,9S)-4,5,12,13-tetramethoxy-17-azatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaene Californine-M, (demethylene-) 2AC Californine-M, (demethylene-methyl-) isomer-2 AC 4,5,12,13-Tetramethoxy-17,17-dimethyl-17-azoniatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaene 13-methyl-5,6,11,12-tetrahydro-5,11-epimino-dibenzo[a,e]cyclooctene Dibenzo[a,e]cycloocten-5,11-imin-4-ol, 5,6,11,12-tetrahydro-3,8-dimethoxy-13-methyl- Californine-M, (di-(demethylene-methyl-)), isomer-3, 2AC Californine-M, (di-(demethylene-methyl-)), isomer-2, 2AC Californine-M (nor-demethylene) 3AC Californine-M, (di-(demethylene-methyl-)), isomer-1, 2AC (1R,9R)-4,5,12,13-tetramethoxy-17-methyl-17-azoniatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaene (+)-Argemonine 17,17-Dimethyl-17-azoniatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaene (±)-pavine 2-Methoxy-5,6,11,12-tetrahydro-dibenzocycloocten-5,11-imin 4,5,12,13-Tetramethoxy-17-prop-2-enyl-17-azatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaene;hydrochloride Dibenzo[a,e]cycloocten-5,11-imine, 5,6,11,12-tetrahydro-2,3,8,9-tetramethoxy-13-(2-propenyl)- Benzo(5,6)cycloocta(1,2-f)-1,3-benzodioxol-5,11-imine, 5,6,11,12-tetrahydro-8,9-dimethoxy-14-methyl-, (5S)- 15-acetyl-5,6,12,13-tetrahydrocycloocta[1,2-f:5,6-f']bis[1,3]benzodioxol-5,12-imine 14-acetyl-5,6,11,12-tetrahydrobenzo[5,6]cycloocta[1,2-f]-1,3-benzodioxol-5,11-imine-8,9-diol 13-acetyl-5,6,11,12-tetrahydrodibenzo[a,e]cycloocten-5,11-imine-2,3,8,9-tetrol norargemonine 4,5,12,13-Tetramethoxy-17-methyl-17-oxido-17-azoniatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4,6,10,12,14-hexaene (±)-pavine